NVO261113C00055000
NVO Nov 13 2026 55.00 Call
optionOPRA
EODOct 21, 2026
0.02USD-33.333%(-0.01)1Vol322OI
Loading…
Underlying
Underlying Price
$38.90
Type
Call
Strike
55
Expiration
Nov 13, 2026
DTE
20d
Moneyness
OTM
Intrinsic
$0.00
NVO 55 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | -1d | $0.01 | -83.33% | 1 | 3 |
| Oct 30, 2026 | 6d | $0.01 | -92.86% | 2 | 80 |
| Nov 6, 2026 | 13d | $0.04 | +300.00% | 2 | 43 |
| Nov 13, 2026 | 20d | $0.02 | -33.33% | 1 | 322 |
| Nov 20, 2026 | 27d | $0.02 | -33.33% | 39 | 3,504 |
| Nov 27, 2026 | 34d | — | — | 0 | 0 |
| Dec 18, 2026 | 55d | $0.08 | +0.00% | 34 | 13,080 |
| Jan 15, 2027 | 83d | $0.17 | +13.33% | 121 | 28,681 |
| Mar 19, 2027 | 146d | $0.58 | +3.57% | 37 | 3,194 |
| Jun 17, 2027 | 236d | $1.17 | +9.35% | 7 | 3,282 |
| Sep 17, 2027 | 328d | $1.75 | -3.31% | 1 | 180 |
| Dec 17, 2027 | 419d | $2.44 | +4.27% | 8 | 3,789 |
| Jan 21, 2028 | 454d | $2.66 | -1.48% | 6 | 3,105 |
| Jun 16, 2028 | 601d | $3.60 | -9.09% | 8 | 1,036 |
| Dec 15, 2028 | 783d | $4.75 | -6.31% | 5 | 1,121 |
| Jan 19, 2029 | 818d | $4.96 | -3.31% | 7 | 94 |
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.